Company

Executive Leadership Team



William Curtis

William W. Curtis

Chief Executive Officer


William Curtis is WaveSense’s Chief Executive Officer and a member of WaveSense’s Board of Directors. Mr. Curtis joined WaveSense in July 2015 and brings over 30 years of experience in the healthcare industry. He has exclusively been involved in healthcare business development and healthcare services since 1983.

Prior to joining WaveSense, Mr. Curtis was the co-founder, Chairman and Chief Executive Officer of CBLPath Holdings Corporation, a specialized anatomic pathology and molecular laboratory that under his leadership experienced organic, profitable revenue growth from $4MM to $85+MM. Previously, he was the founder and Chief Executive Officer of MLC International and The Hillside Group, healthcare financial and business development companies.

Mr. Curtis majored in Philosophy at Providence College.



Chris Feistel

Christopher C. Feistel

Co-Founder & Chief Technology Officer


Christopher Feistel is WaveSense’s Co-Founder & Chief Technology Officer. Mr. Feistel co-founded WaveSense and brings over 30 years of experience in the healthcare industry. Mr. Feistel has developed 100+ medical products from concept to market, many of which were acquired and sold by Johnson & Johnson, Baxter Healthcare, Eli Lilly (IVAC), Smith Kline, Beckman, Sigma Diagnostics, Pacific Biometrics, and Qualigen.

Prior to joining WaveSense, Mr. Feistel was the Owner/Operator of Salt Creek Labs; General Manager of Merchant House Scientific; Chief Operating Officer/ General Manager of Qualigen; General Manager/Director of Regulatory Affairs of Diagnostics Solutions Inc.

Mr. Feistel holds 9 US patents (6 U.S. patents as sole inventor) and 10 International patents.



Peter Hartmayer

Peter Hartmayer

Executive Vice President of Sales


Peter Hartmayer is WaveSense’s Executive Vice President of Sales. Mr. Hartmayer joined WaveSense in early 2014 and brings over 30 years of experience in the medical device industry. He is a seasoned, accomplished leader with a consistent record of innovation and achievement creating sales and marketing initiatives in the rapidly changing Pathology/Molecular Oncology/Biotech environment.

Prior to joining WaveSense, Mr. Hartmayer was the Executive Vice President and co-founder of Cymogen DX. Mr. Hartmayer's extensive background consists of various executive management positions, Vice President of Sales for Neodiagnostix, Executive Vice President/co-founder of CGI as well as other executive sales positions with Insight Biomedical, Vysis, Genetrix, Gen-Care Biomedical, Hybritech and Abbott Laboratories.